Literature DB >> 8313374

Equal transcription of wild-type and mutant p53 using bicistronic vectors results in the wild-type phenotype.

T Frebourg1, M Sadelain, Y S Ng, J Kassel, S H Friend.   

Abstract

Somatic and germ-line mutations of p53 alleles inactivate the function of the protein. It has been suggested that mutant p53 can inactivate the wild-type protein and therefore have a trans-dominant negative effect. To investigate the interaction between wild-type and mutant proteins when both alleles are equally transcribed, we designed bicistronic vectors containing the internal ribosome entry site of the encephalomyocarditis virus and expressing wild-type and mutant p53. Analysis of the transcriptional activity and of the effect on cell growth of these plasmids indicates that the mutant protein is unable to completely suppress wild-type function. These results could explain why the inactivation of both p53 alleles is required in cancer development.

Entities:  

Mesh:

Year:  1994        PMID: 8313374

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  How many mutant p53 molecules are needed to inactivate a tetramer?

Authors:  Wan Mui Chan; Wai Yi Siu; Anita Lau; Randy Y C Poon
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

2.  Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis.

Authors:  W A Franklin; A F Gazdar; J Haney; I I Wistuba; F G La Rosa; T Kennedy; D M Ritchey; Y E Miller
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

Review 3.  Immunotherapy III: Combinatorial molecular immunotherapy--a synthesis and suggestions.

Authors:  R G Vile; H Chong
Journal:  Cancer Metastasis Rev       Date:  1996-09       Impact factor: 9.264

4.  p53 mutants have selective dominant-negative effects on apoptosis but not growth arrest in human cancer cell lines.

Authors:  O N Aurelio; X T Kong; S Gupta; E J Stanbridge
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

5.  Cells exposed to antifolates show increased cellular levels of proteins fused to dihydrofolate reductase: a method to modulate gene expression.

Authors:  Philipp Mayer-Kuckuk; Debabrata Banerjee; Sundeep Malhotra; Mikhail Doubrovin; Marian Iwamoto; Tim Akhurst; Julius Balatoni; William Bornmann; Ronald Finn; Steven Larson; Yuman Fong; Juri Gelovani Tjuvajev; Ronald Blasberg; Joseph R Bertino
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

6.  Translational modulation of proteins expressed from bicistronic vectors.

Authors:  Prasun J Mishra; Lata G Menon; Pravin J Mishra; Philipp Mayer-Kuckuk; Joseph R Bertino; Debabrata Banerjee
Journal:  Mol Imaging       Date:  2009-12       Impact factor: 4.488

7.  Gain-of-function mutations of the p53 gene induce lymphohematopoietic metastatic potential and tissue invasiveness.

Authors:  M Hsiao; J Low; E Dorn; D Ku; P Pattengale; J Yeargin; M Haas
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

8.  Spontaneous in vitro immortalization of breast epithelial cells from a patient with Li-Fraumeni syndrome.

Authors:  J W Shay; G Tomlinson; M A Piatyszek; L S Gollahon
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

Review 9.  p53 tetramerization: at the center of the dominant-negative effect of mutant p53.

Authors:  Jovanka Gencel-Augusto; Guillermina Lozano
Journal:  Genes Dev       Date:  2020-09-01       Impact factor: 11.361

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.